Paradigm Medical Industries, Inc. (PDMI)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2011 | 3.4 Million USD | 0.24% |
| 2010 | 3.39 Million USD | -20.88% |
| 2009 | 4.28 Million USD | -14.55% |
| 2008 | 5.01 Million USD | 16.3% |
| 2007 | 4.31 Million USD | 11.85% |
| 2006 | 3.85 Million USD | 19.97% |
| 2005 | 3.21 Million USD | 92.4% |
| 2004 | 1.67 Million USD | -25.47% |
| 2003 | 2.24 Million USD | -8.19% |
| 2002 | 2.44 Million USD | -17.83% |
| 2001 | 2.97 Million USD | 54.87% |
| 2000 | 1.91 Million USD | 379.75% |
| 1999 | 400 Thousand USD | -20.0% |
| 1998 | 500 Thousand USD | -77.27% |
| 1997 | 2.2 Million USD | 1000.0% |
| 1996 | 200 Thousand USD | -50.0% |
| 1995 | 400 Thousand USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2011 FY | 3.4 Million USD | 0.24% |
| 2010 FY | 3.39 Million USD | -20.88% |
| 2009 FY | 4.28 Million USD | -14.55% |
| 2009 Q1 | 4.76 Million USD | -5.02% |
| 2008 Q2 | 4.72 Million USD | 8.34% |
| 2008 Q3 | 4.97 Million USD | 5.25% |
| 2008 Q4 | 5.01 Million USD | 0.86% |
| 2008 Q1 | 4.36 Million USD | 1.11% |
| 2008 FY | 5.01 Million USD | 16.3% |
| 2007 Q3 | 4.87 Million USD | -1.12% |
| 2007 Q1 | 3.94 Million USD | 2.31% |
| 2007 Q2 | 4.93 Million USD | 24.99% |
| 2007 Q4 | 4.31 Million USD | -11.54% |
| 2007 FY | 4.31 Million USD | 11.85% |
| 2006 FY | 3.85 Million USD | 19.97% |
| 2006 Q1 | 3.51 Million USD | 9.24% |
| 2006 Q2 | 3.9 Million USD | 11.3% |
| 2006 Q4 | 3.85 Million USD | 1.79% |
| 2006 Q3 | 3.78 Million USD | -3.07% |
| 2005 Q3 | 3.4 Million USD | -6.43% |
| 2005 FY | 3.21 Million USD | 92.4% |
| 2005 Q1 | 1.58 Million USD | -4.91% |
| 2005 Q2 | 3.64 Million USD | 129.14% |
| 2005 Q4 | 3.21 Million USD | -5.64% |
| 2004 Q2 | 1.85 Million USD | -18.76% |
| 2004 FY | 1.67 Million USD | -25.47% |
| 2004 Q4 | 1.67 Million USD | -2.74% |
| 2004 Q1 | 2.28 Million USD | 1.78% |
| 2004 Q3 | 1.71 Million USD | -7.34% |
| 2003 Q4 | 2.24 Million USD | -12.01% |
| 2003 FY | 2.24 Million USD | -8.19% |
| 2003 Q3 | 2.54 Million USD | -15.88% |
| 2003 Q1 | 2.6 Million USD | 6.51% |
| 2003 Q2 | 3.02 Million USD | 16.46% |
| 2002 FY | 2.44 Million USD | -17.83% |
| 2002 Q4 | 2.44 Million USD | -17.75% |
| 2002 Q3 | 2.96 Million USD | -2.85% |
| 2002 Q2 | 3.05 Million USD | 23.82% |
| 2002 Q1 | 2.46 Million USD | -16.96% |
| 2001 Q1 | 1.93 Million USD | 0.78% |
| 2001 FY | 2.97 Million USD | 54.87% |
| 2001 Q4 | 2.97 Million USD | 12.62% |
| 2001 Q3 | 2.63 Million USD | -18.67% |
| 2001 Q2 | 3.24 Million USD | 67.79% |
| 2000 Q2 | 1.56 Million USD | 237.37% |
| 2000 Q3 | 1.34 Million USD | -13.89% |
| 2000 Q4 | 1.91 Million USD | 42.68% |
| 2000 Q1 | 463 Thousand USD | 15.75% |
| 2000 FY | 1.91 Million USD | 379.75% |
| 1999 Q3 | 600 Thousand USD | -25.0% |
| 1999 Q4 | 400 Thousand USD | -33.33% |
| 1999 FY | 400 Thousand USD | -20.0% |
| 1999 Q1 | 500 Thousand USD | 0.0% |
| 1999 Q2 | 800 Thousand USD | 60.0% |
| 1998 Q2 | 500 Thousand USD | -37.5% |
| 1998 Q1 | 800 Thousand USD | -63.64% |
| 1998 FY | 500 Thousand USD | -77.27% |
| 1998 Q4 | 500 Thousand USD | 150.0% |
| 1998 Q3 | 200 Thousand USD | -60.0% |
| 1997 Q4 | 2.2 Million USD | 120.0% |
| 1997 Q2 | 1.3 Million USD | -7.14% |
| 1997 FY | 2.2 Million USD | 1000.0% |
| 1997 Q3 | 1 Million USD | -23.08% |
| 1997 Q1 | 1.4 Million USD | 250.0% |
| 1996 Q3 | 200 Thousand USD | -81.82% |
| 1996 Q2 | 1.1 Million USD | 0.0% |
| 1996 FY | 200 Thousand USD | -50.0% |
| 1996 Q4 | 400 Thousand USD | 100.0% |
| 1995 FY | 400 Thousand USD | 0.0% |
| 1995 Q3 | 400 Thousand USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| American Medical Technologies Inc. | 2.34 Million USD | -44.69% |
| Ansell Limited | 1.32 Billion USD | 99.744% |
| Ansell Limited | 1.33 Billion USD | 99.745% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 126.33 Million USD | 97.309% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 943.17 Thousand USD | -260.486% |
| Psykey, Inc. | 2.47 Million USD | -37.428% |
| ConvaTec Group Plc | 2.01 Billion USD | 99.832% |
| ConvaTec Group Plc | 2.02 Billion USD | 99.832% |
| Encision Inc. | 1.98 Million USD | -71.374% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | 3.04 Million USD | -11.824% |
| Innovative MedTech Inc. | 6.13 Million USD | 44.579% |
| LifePoint, Inc. | 2.45 Million USD | -38.54% |
| Medite Cancer Diagnostics, Inc. | 10.18 Million USD | 66.604% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 3.04 Million USD | -11.83% |
| Reflect Scientific, Inc. | 776.32 Thousand USD | -337.959% |
| SmileDirectClub, Inc. | 982.26 Million USD | 99.654% |
| Sector 10, Inc. | 9.84 Million USD | 65.466% |
| Shandong Weigao Group Medical Polymer Company Limited | 1.35 Billion USD | 99.749% |
| SheerVision, Inc. | 1.43 Million USD | -137.529% |
| United Health Products, Inc. | 1.99 Million USD | -70.096% |
| Vasamed, Inc. | 1 Million USD | -238.208% |
| Wearable Health Solutions, Inc. | 3.8 Million USD | 10.533% |
| Yubo International Biotech Limited | 2.91 Million USD | -16.681% |